Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 646

1.

Hyperuricemia and gout: new insights into pathogenesis and treatment.

Pillinger MH, Rosenthal P, Abeles AM.

Bull NYU Hosp Jt Dis. 2007;65(3):215-21. Review.

2.

[Therapy of hyperuricemia and gout].

Pöllmann G, Kullich W, Klein G.

Wien Med Wochenschr. 1997;147(16):382-7. Review. German.

PMID:
9446417
3.

Gout Study Group: update on hyperuricemia and gout.

Terkeltaub R, Zelman D, Scavulli J, Perez-Ruiz F, Lioté F.

Joint Bone Spine. 2009 Jul;76(4):444-6. doi: 10.1016/j.jbspin.2009.05.006. Epub 2009 Jun 25. No abstract available.

PMID:
19559637
4.

Colchicine and other drugs for gout.

[No authors listed]

Med Lett Drugs Ther. 2009 Nov 30;51(1326):93-4. Review. No abstract available.

PMID:
20224523
5.

[Increased uric acid values: when must medication treatment be instituted?].

Bischoff A.

MMW Fortschr Med. 2010 Jun 10;152(23):20. German. No abstract available.

PMID:
20608458
6.

The management of gout: it should be crystal clear.

Wortmann RL.

J Rheumatol. 2006 Oct;33(10):1921-2. No abstract available.

7.

New agents for the treatment of gout and hyperuricemia: febuxostat, puricase, and beyond.

Schlesinger N.

Curr Rheumatol Rep. 2010 Apr;12(2):130-4. doi: 10.1007/s11926-010-0093-2. Review.

PMID:
20425022
8.

The management of gout.

Emmerson BT.

N Engl J Med. 1996 Feb 15;334(7):445-51. Review.

PMID:
8552148
9.

Preventing and treating acute gout attacks across the clinical spectrum: a roundtable discussion.

Mandell BF, Edwards NL, Sundy JS, Simkin PA, Pile JC.

Cleve Clin J Med. 2010 Jun;77 Suppl 2:S2-25. doi: 10.3949/ccjm.77.s2.01. No abstract available.

10.

An update on the treatment options for gout and calcium pyrophosphate deposition.

Choy G.

Expert Opin Pharmacother. 2005 Nov;6(14):2443-53. Review.

PMID:
16259576
11.

Uricase and other novel agents for the management of patients with treatment-failure gout.

Sundy JS, Hershfield MS.

Curr Rheumatol Rep. 2007 Jun;9(3):258-64. Review.

PMID:
17531181
12.

[Hyperuricemia and gout: diagnosis and therapy].

Tausche AK, Unger S, Richter K, Wunderlich C, Grässler J, Roch B, Schröder HE.

Internist (Berl). 2006 May;47(5):509-20; quiz 521. German.

PMID:
16586130
13.

Update on gout: pathophysiology and potential treatments.

Abeles AM, Park JY, Pillinger MH, Cronstein BN.

Curr Pain Headache Rep. 2007 Dec;11(6):440-6. Review.

PMID:
18173979
14.

Updates in the management of gout.

Keith MP, Gilliland WR.

Am J Med. 2007 Mar;120(3):221-4. Review.

PMID:
17349440
15.

Recent advances in management of gout.

Suresh E, Das P.

QJM. 2012 May;105(5):407-17. doi: 10.1093/qjmed/hcr242. Epub 2011 Dec 23. Review.

PMID:
22198943
16.

Hyperuricaemia and gout.

Shipley M.

J R Coll Physicians Edinb. 2011 Sep;41(3):229-33. doi: 10.4997/JRCPE.2011.311.

PMID:
21949921
17.

A new perspective on the pharmacoeconomics of colchicine.

Wertheimer AI, Davis MW, Lauterio TJ.

Curr Med Res Opin. 2011 May;27(5):931-7. doi: 10.1185/03007995.2011.563284. Epub 2011 Mar 3. Review.

PMID:
21370937
18.

Antihyperuricemic properties of amflutizole in gout.

Wortmann RL, Ridolfo AS, Lightfoot RW Jr, Fox IH.

J Rheumatol. 1985 Jun;12(3):540-3.

PMID:
3900392
19.

Hyperuricemia and gout.

Sloan RW.

J Fam Pract. 1982 May;14(5):923-6, 930-1, 934. Review.

PMID:
7042900
20.

New developments in clinically relevant mechanisms and treatment of hyperuricemia.

Lee SJ, Terkeltaub RA.

Curr Rheumatol Rep. 2006 Jun;8(3):224-30. Review.

PMID:
16901081

Supplemental Content

Support Center